Quality key factors
Factor
Value
Sales Growth (5y)
-18.48%
EBIT Growth (5y)
11.35%
EBIT to Interest (avg)
-14.66
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.87
Sales to Capital Employed (avg)
0.21
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
Industry P/E
Price to Book Value
NA
EV to EBIT
0.07
EV to EBITDA
0.07
EV to Capital Employed
-0.19
EV to Sales
-0.39
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-302.41%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Technical Movement
13What is working for the Company
ROCE(HY)
Highest at -97.1%
RAW MATERIAL COST(Y)
Fallen by -99.86% (YoY
PRE-TAX PROFIT(Q)
At SEK -0.47 MM has Grown at 49.28%
NET PROFIT(Q)
At SEK -0.47 MM has Grown at 49.28%
EPS(Q)
Highest at SEK -0
-11What is not working for the Company
NET SALES(HY)
At SEK 0.06 MM has Grown at -85.87%
CASH AND EQV(HY)
Lowest at SEK 2.57 MM
DEBT-EQUITY RATIO
(HY)
Highest at -18.9 %
DEBTORS TURNOVER RATIO(HY)
Lowest at 0.31 times
Here's what is working for Double Bond Pharmaceutical International AB
Pre-Tax Profit
At SEK -0.47 MM has Grown at 49.28%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (SEK MM)
Net Profit
At SEK -0.47 MM has Grown at 49.28%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is positive
Net Profit (SEK MM)
EPS
Highest at SEK -0
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (SEK)
Raw Material Cost
Fallen by -99.86% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Double Bond Pharmaceutical International AB
Net Sales
At SEK 0.06 MM has Grown at -85.87%
Year on Year (YoY)MOJO Watch
Near term sales trend is very negative
Net Sales (SEK MM)
Cash and Eqv
Lowest at SEK 2.57 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Debt-Equity Ratio
Highest at -18.9 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Debtors Turnover Ratio
Lowest at 0.31 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio






